WTA
HCAT icon

Washington Trust Advisors’s Health Catalyst HCAT Stock Holding History

Washington Trust Advisors’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-573
Closed -$23K – 1009
2021
Q4 		$23K Buy
+573
New +$26.1K ﹤0.01% 607

Other funds holding HCAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Washington Trust Advisors's HCAT Position: Q1 2022 in Review

Washington Trust Advisors sold out of Health Catalyst (HCAT) in Q1 2022, closing a stake of 573 shares — an estimated $23K sold.

Washington Trust Advisors first reported a position in HCAT in Q4 2021 and held it in 1 quarter. The position peaked at $23K in Q4 2021. 185 funds tracked by Wall St. Rank hold HCAT as of Q1 2022.

  • Washington Trust Advisors reported no remaining Health Catalyst position as of Q1 2022 after selling out during the quarter.
  • Washington Trust Advisors sold 573 Health Catalyst shares in Q1 2022, an estimated $23K.
  • Washington Trust Advisors first reported a position in Health Catalyst in Q4 2021 and held it in 1 quarter.
  • Washington Trust Advisors's Health Catalyst position peaked at $23K in Q4 2021.
  • 185 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2022.

Based on Washington Trust Advisors's 13F filing for Q1 2022, filed 5 May 2022.